The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex
Nicola Ivan Lorè, Fabio Saliu, Andrea Spitaleri, Daniel Schäfle, Francesca Nicola, Daniela Maria Cirillo, Peter Sander
Source: Eur Respir J, 60 (6) 2201541; 10.1183/13993003.01541-2022
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicola Ivan Lorè, Fabio Saliu, Andrea Spitaleri, Daniel Schäfle, Francesca Nicola, Daniela Maria Cirillo, Peter Sander. The aminoglycoside-modifying enzyme Eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in Mycobacterium abscessus complex. Eur Respir J, 60 (6) 2201541; 10.1183/13993003.01541-2022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|